Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA5A | P35218 | 1/20 | 0.40 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | TP53 | P04637 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | GMNN | O75496 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1132267 | 0.90 | CA2 (0.35) | ALDH1A1KDM4ELMNAGMNNPOLB | |
| Sulfuric Acid SCHEMBL1131387 | 0.85 | MEN1 (0.42) | ALDH1A1KMT2A | |
| Sulfuric Acid SCHEMBL1344260 | 0.84 | CA5A (0.38) | CA5ACA5BALDH1A1KDM4ETP53 | |
| SCHEMBL7791046 | 0.83 | CA2 (0.32) | CA1CA2 | |
| SCHEMBL14112035 | 0.82 | — | — | |
| SCHEMBL5944 | 0.82 | — | — | |
| Trifluoromethanesulfonic Acid SCHEMBL1131470 | 0.81 | ALDH1A1 (0.33) | ALDH1A1 | |
| Sulfuric Acid SCHEMBL576878 | 0.80 | CA5A (0.40) | CA5ACA5BALDH1A1KDM4ETP53 | |
| Lithium SCHEMBL1395029 | 0.78 | — | — | |
| Bromide SCHEMBL313669 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8784686-B2 | Liquids | INNOVIA FILMS LIMITED (GB) | 2014-07-22 | — | — | US | claimed |
| EP-1805131-B1 | IONIC LIQUIDS COMPRISING NITROGEN CONTAINING CATIONS | INNOVIA FILMS LTD (GB) | 2011-02-16 | — | — | EP | claimed |
| US-20070185330-A1 | Liquids | THE UNIVERSITY OF YORK (GB) | 2007-08-09 | — | — | US | claimed |
| EP-4218730-B1 | LIPOSOMES USEFUL FOR DRUG DELIVERY | IPSEN BIOPHARM LTD (GB) | 2023-11-01 | — | — | EP | disclosed |
| EP-4218730-A1 | LIPOSOMES USEFUL FOR DRUG DELIVERY | Ipsen Biopharm Ltd. (GB) | 2023-08-02 | — | — | EP | disclosed |
| US-20230181567-A1 | Liposomes Useful for Drug Delivery | IPSEN BIOPHARM LTD. (GB) | 2023-06-15 | — | — | US | disclosed |
| US-11052079-B2 | Liposomes useful for drug delivery | IPSEN BIOPHARM LTD. | 2021-07-06 | — | — | US | disclosed |
| US-20210137914-A1 | Liposomes Useful for Drug Delivery | IPSEN BIOPHARM LTD. (GB) | 2021-05-13 | — | — | US | disclosed |
| US-10722508-B2 | Liposomes useful for drug delivery | IPSEN BIOPHARM LTD. (GB) | 2020-07-28 | — | — | US | disclosed |
| US-10413510-B2 | Liposomes useful for drug delivery | IPSEN BIOPHARM LTD. (GB) | 2019-09-17 | — | — | US | disclosed |
| US-10350201-B2 | Liposomes useful for drug delivery | IPSEN BIOPHARM LTD. (GB) | 2019-07-16 | — | — | US | disclosed |
| EP-2322497-A1 | Ionic liquids comprising nitrogen containing cations | Innovia Films Limited (GB) | 2011-05-18 | — | — | EP | disclosed |
| EP-1805131-B1 | IONIC LIQUIDS COMPRISING NITROGEN CONTAINING CATIONS | INNOVIA FILMS LTD (GB) | 2011-02-16 | — | — | EP | disclosed |
| CN-101316810-A | Ionic liquids | BIONIQS LTD (GB) | 2008-12-03 | — | — | CN | disclosed |
| US-20080221361-A1 | Ionic Liquids | BIONIQS LIMITED (GB) | 2008-09-11 | — | — | US | disclosed |
| US-20070185330-A1 | Liquids | THE UNIVERSITY OF YORK (GB) | 2007-08-09 | — | — | US | disclosed |
| US-20070116753-A1 | Liposomes useful for drug delivery | HERMES BIOSCIENCES, INC. (US) | 2007-05-24 | — | — | US | disclosed |
| US-20070110798-A1 | Liposomes useful for drug delivery to the brain | HERMES BIOSCIENCES, INC. (US) | 2007-05-17 | — | — | US | disclosed |
| EP-1746976-A1 | LIPOSOMES USEFUL FOR DRUG DELIVERY | Hermes Biosciences, Inc. (US) | 2007-01-31 | — | — | EP | disclosed |
| WO-2005107712-A1 | LIPOSOMES USEFUL FOR DRUG DELIVERY | HERMES BIOSCIENCES, INC. (US) | 2005-11-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11052079-B2 | Liposomes useful for drug delivery | ABHD16A, LIPA, AGPAT5 | CA5A 480/4885CA5B 658/4885ALDH1A1 4120/4885 |
| US-10413510-B2 | Liposomes useful for drug delivery | ABHD16A, LIPA, AGPAT5 | CA5A 480/4885CA5B 658/4885ALDH1A1 4120/4885 |
| US-20210137914-A1 | Liposomes Useful for Drug Delivery | ABHD16A, LIPA, AGPAT5 | CA5A 480/4885CA5B 658/4885ALDH1A1 4120/4885 |
| US-20230181567-A1 | Liposomes Useful for Drug Delivery | ABHD16A, LIPA, AGPAT5 | CA5A 480/4885CA5B 658/4885ALDH1A1 4120/4885 |
| US-20070116753-A1 | Liposomes useful for drug delivery | ABHD16A, LIPA, AGPAT5 | CA5A 480/4885CA5B 658/4885ALDH1A1 4120/4885 |
| US-10350201-B2 | Liposomes useful for drug delivery | ABHD16A, LIPA, AGPAT5 | CA5A 480/4885CA5B 658/4885ALDH1A1 4120/4885 |
| US-10722508-B2 | Liposomes useful for drug delivery | ABHD16A, LIPA, AGPAT5 | CA5A 480/4885CA5B 658/4885ALDH1A1 4120/4885 |
| US-20070110798-A1 | Liposomes useful for drug delivery to the brain | ATP6V1B2, LPCAT3, AGPAT5 | CA5A 482/4885CA5B 645/4885ALDH1A1 4534/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.